Aakash Manoj, the teen prodigy who invented a non-invasive device to detect silent heart attacks and save thousands of lives, enlightened the audience about his invention on the second day of the Healthcare Senate 2018.
Manoj said, “After having researched for about three years, I’ve been able to develop a non-invasive device that is inexpensive, portable, and wearable by at-risk patients. It needs no blood test and works 24/7, collecting and analysing data in preset intervals, and what is even more special is that it can detect heart attacks upto six hours in advance.”
Explaining about the non-invasive device, Manoj said, “The levels of a cardiac biomarker called h-FABP enables early detection, as against the conventional detection of Troponin in expensive Trop-T tests at hospitals today. A system like this could do away the need for an at-risk patient to go to a doctor for a biomarker blood test because the device could be worn at all times, sensing biomarker elevations in-vivo. If the device senses the biomarker levels going beyond the critical point, the at-risk patient could be warned of an impending cardiac arrest and that he/she needs immediate medical attention. When I got my device tested on at-risk patients under observation at AIIMS, New Delhi and the Tokyo University of Science, results certified 96.46 per cent accuracy and sensitivity. This could indeed transform the diagnostic protocol that medical community currently adheres to.”
Moving forward, he would want his innovation to be available to people in two variants. One, which gives a digital analysis of the biomarker levels. And a simpler version for the people in rural areas, which simply vibrates when the levels of the biomarker steadily rises.
He also highlighted the need to establish proactive healthcare system and fund researches in which patients are co-designers, co-developers, and thereby, increasingly more responsible for their own and collective health outcomes.
Watch full video here:
- Advertisement -
Comments are closed.